|
Scientific Publications:
Shia J, Teruya-Feldstein J, Pan D, Hedge A, Klimstra
DS, Chaganti RSK, Qin J, Portlock CS, Filippa DA:
Primary follicular lymphoma of the gastrointestinal
tract: a clinical and pathological study of 26 cases.
Amer J Surg Path Feb 2002;26(2):216-224.
Laurie SA, Kris MG, Portlock CS, Rosenzweig KE, Miller
VA, Krug LM, Rusch VW: The clinical course of non
small cell lung cancer in survivors of Hodgkin's disease.
Cancer 2002;95(1):119-26.
Ripp JA, Louie DS, Chan W, Nawaz H. Portlock CS:
T-cell rich B-cell lymphoma: clinical distinctiveness
and response to treatment in 45 patients. Leuk Lymphoma
2002 Aug;43(8):1573-80.
Pan D, Moskowitz CH, Zelenetz AD, Straus D, Kewalaramani
T, Noy A, Qin J, Teruya-Feldstein J, Portlock CS:
Rituximab for aggressive non-Hodgkin's lymphomas relapsing
after or refractory to autologous stem cell transplantation.
Cancer J. 2002 Sep-Oct;8(5):371-6.
Pan D, Qin J, Farber C, O'Brien J, Filippa D, Portlock
CS: CHOP with high dose Cyclophosphamide consolidation
vs CHOP alone as initial therapy for advanced stage,
indolent non-Hodgkin's lymphoma. Leuk Lymphoma, 2002
(in press).
Portlock CS: "Stanford V and Radiotherapy for
Hodgkin's Disease" Current Oncology Reports 2002;4(5):413.
Portlock CS: "CHOP and Rituximab in Elderly
Patients" Current Oncology Reports 2002;4(5):414.
Portlock CS: "Dose density and dose intensity:
where does CHOP go from here?" Ann Oncol 2002;13:1329-1330.
Goy A, Gilles F, Remache Y, Filippa D, Portlock CS,
Jhanwar SC, Zelenetz AD: Establishment of a human
cell line (SKI-DLCL-1) with a t(1;14)(q21;q32) translocation
from the ascites of a patient with diffuse large cell
lymphoma. Leuk Lymphoma Jan 2001;40(3-4):419-23.
Moskowitz G, Nimer SD, Zelenetz AD, Trippett T, Hedrick
EE, Filippa D, Louie D, Gonzales M, Walits J, Coady-Lyons
N, Qin J, Frank R, Bertino JR, Goy A, Noy A, O'Brien
JP, Straus D, Portlock CS, Yahalom J: A two-step comprehensive
high-dose chemotherapy second-line program for relapsed
and refractory Hodgkin's disease: analysis by intent
to treat and development of a prognostic model. Blood
Feb 2001;97(3):616-623.
Donnelly GB, Glassman J, Long C, Torres P, Straus
DJ, O'Brien JP, Bertino J, Moskowitz CH, Zelenetz
AD, Portlock CS: Granulocyte-colony stimulating factor
(G-CSF) may improve disease outcome in elderly patients
with diffuse large cell lymphoma (DLCL) treated with
CHOP chemotherapy. Leuk Lymphoma 2000;39(1-2):67-75.
Portlock CS: "New developments in lymphoma clinical
trials" Current Oncology Reports 2000;2:154-156.
Moskowitz CH, Nimer SD, Glassman JR, Portlock CS,
Yahalom J, Straus DJ, O'Brien JP, Elkin N, Bertino
JR, Zelenetz AD: The International Prognostic Index
predicts for outcome following autologous stem cell
transplantation in patients with relapsed and primary
refractory intermediate-grade lymphoma. Bone Marrow
Transplant 1999;23(6):561-7.
Moskowitz CH, Bertino JR, Glassman JR, Hedrick EE,
Hunte S, Coady-Lyons N, Agus DB, Goy A, Jurcic J,
Noy A, O'Brien J, Portlock CS, Straus DS, Childs B,
Frank R, Yahalom J, Filippa D, Louie D, Nimer SD,
Zelenetz AD: Ifosfamide, carboplatin, and etoposide:
a highly effective cytoreduction and peripheral-blood
progenitor-cell mobilization regimen for transplant-eligible
patients with non-Hodgkin's lymphoma. J Clin Oncol
1999;17(12): 3776-85.
Schechter NR, Portlock CS, and Yahalom J: Treatment
ofMucosa-Associated Lymphoid Tissue Lymphoma of the
Stomach with Radiation Alone. J Clin Oncol 1998;16:1916-1921.
Gale RP, Park RE, DuBois R, Bierman PJ, Fisher RI,
Loh KK, Peterson BA, Phillips GL, Portlock CS, Rosenblum
D, Armitage JO: Delphi-panel Analysis of Appropriateness
of High-Dose Chemotherapy and Blood Cell or Bone Marrow
Autotransplants in Diffuse Large Cell Lymphoma. Leukemia
and Lymphoma 1998;32(1-2):139-140.
Pavlick A, Gerdes H, Portlock C: "Endoscopic
Ultrasound (EUS) in the Evaluation of Gastric Small
Lymphocytic Mucosa-Associated Lymphoid Tumors (MALT)."
J Clin Oncol 1997;15:1761-1766.
Hirsch A, Vander-Els N, Gomez E, Leung D, Portlock
C, Straus D, and Yahalom J: "The Effect of ABVD
Chemotherapy With and Without Mediastinal Irradiation
on Pulmonary Function and Symptoms in Early Stage
Hodgkin's Disease." J Clin Oncol 1996;14:1297-1305.
Wong ET, Portlock CS, O'Brien JP, DeAngelis LA: "Chemo-sensitive
Epidural Spinal Cord Disease in Non-Hodgkin's Lymphoma"
Neurology 1996;46:1543-1547.
Filippa DA, Ladanyi M, Wollner N, Straus DJ, O'Brien
JP, Portlock C, Gangi M and Sun M: "CD 30 (Ki-1)-Positive
Malignant Lymphomas: Clinical, Immunophenotypic, Histologic,
and Genetic Characteristics and Differences with Hodgkin's
Disease." Blood April 1996;87(7):2905-2917.
Castellino RA, Hilton S, O'Brien JP, and Portlock
CS: "Non-Hodgkin Lymphoma: Contribution of Chest
CT in the Initial Staging Evaluation." Radiology
1996;199:129-132.
Lieberman FS, Portlock C: "Recurrent Episodes
of Transient Memory Disturbance After Unilateral Thalamic
Infarction in a Hodgkin's Disease Patient With Herpes
Zoster." Journal of Neurovascular Disease July/Aug
1996:9-11.
Younes A, Cabanillas P, McLaughlin PW, Hagemeister
FB, Farber C, Sarris A, Pate O, Myers J, and Portlock
C: "Preliminary Experience with Paclitaxel for
the Treatment of Relapsed and Refractory Hodgkin's
Disease." Annals of Oncology 1996;7:1083-1085.
Offit K, LoCoco F, Louie D, Parsa N, Leung D, Portlock
C, Ye B, Lista F, Filippa D, Rosenbaum A, Ladanyi
M, Jhanwar S, Dalla-Favera R, and Chaganti R. "Rearrangement
of the bcl-6 Gene as a Prognostic Marker in Diffuse
Large Cell Lymphoma" N Eng J Med 1994;331(2):74-80.
O'Brien JP, O'Keefe P, Alvares A, and Portlock, CS.
"The NHL-15 Protocol for Intermediate Grade and
Immunoblastic LYmphoma: A Dose intense program of
Doxorubicin, Vincristine and Cyclophosphamide"
Hem/Onc Annals 1993;1:47-50.
Yahalom J, Gulati CS, Toia M, Maslak P, McCarron
EG, O'Brien JP, Portlock CS, Straus DJ, Phillips J,
and Fuks Z. "Accelerated Hyperfractionated Total-Lymphoid
Irradiation, High-Dose Chemotherapy and Autologous
Bone Marrow Transplantation for Refractory and Relapsing
Patients with Hodgkin's Disease" J Clin Oncol
1993;11:1062-1070.
Atiq OT, Deangelis LM, Rosenblum M, and Portlock.
"Cutaneous T-cell lymphoma presenting with diffuse
lymphomatous infiltration of the peripheral nerves:
Response to combination chemotherapy" Am J Clin
Oncol 1992;15:212-215.
Kostak L, Yeh SDJ, Portlock CS, Heelan R, Tao T-J,
Niedzwiecki D, and Larson SM. "Validation of
Ga-67 Citrate, Single Photon Emission Computed Tomography
(SPECT) in Biopsy Confirmed Residual Hodgkin's Disease
in the Mediastinum" J Nucl Med 1992;33:345-350.
Portlock CS: "Management of Non-Hodgkin's lymphoma"
Int J Clin Lab Res 1992;22(2):81-83.
Portlock CS: ?Greater curability in advanced Hodgkin's
disease?? Cancer J Sci Am 1999 Sept-Oct;5(5):264-5.
Golomb HM, Fefer A, Golde DW, Ozer H, Portlock CS,
Silber R, Rappeport J, Ratain MJ, Thompson J, Bonnem
E, Spiegel R, Tensen L, Burke JS, and Vardiman JW.
"Survival experience of 195 patients with hairy
cell leukemia treated in a multi-institutional study
with interferon-alfa 2B" Leukemia and Lymphoma,
1991.
Murren JR, DeRosa W, Durviage HJ, Davis C, Makuch
R, and Portlock CS. "High-dose cisplatin plus
dacarbazine in the treatment of metastatic melanoma"
Cancer 1991;67:1514.
Subhash C. Gulati, Kathy Jules-Elysee, Karla Whitmarsh,
Joachim Yahalom, M.D., Lillian Reich, John Crown,
Robert Motzer, Morton Coleman, Roberto M. Lemoli,
Bayard D. Clarkson, Carol Portlock, Timothy Gee, and
John Mendelsohn. "Factors Affecting The Outcome
of Autologous Bone Marrow Transplantation" Autologous
Bone Marrow Transplantation, ed. Karen A. Dicke, James
O. Armitage and Mary Jean Dicke-Evinger, 1991:405-410.
Mai DH-W, Peschel RE, Portlock C, Knowlton A, and
Farber L. "Stage I and II subdiaphragmatic Hodgkin's
disease" Cancer 1991;68:1476-1481.
Thomas A. Steffens, Dean F. Bajorin, Paul B. Chapman,
David R. Lovett, Beverly V. Cody-Johnson, Mary Agnes
Templeton, Robert T. Heelan, George Y. Wong, Carol
S. Portlock, Herbert F. Oettgen and Alan N. Houghton.
"A Phase II Trial of High-Dose Cisplatin and
Dacarbazine" Cancer 1991;68:1230-1237.
Gulati S, Portlock CS, Yahalom J: "Autologous
Bone Marrow Transplantation" Current Problems
in Cancer 1991;15(1):1-57.
Murren JR and Portlock CS. "Non-Hodgkin's lymphoma:
Current Therapy for low grade histologies" Adv
Oncol 1991;7:9-14.
Dowling SW, Peschel RE, Portlock CS, Kramer C, Farber
LR, and Knowlton AH. "Mediastinal irradiation
in combined modality therapy for Hodgkin's disease"
Int J Radiat Oncol Biol Phys 1990;19:543-546.
Henry-Amar M and Somers R (CS Portlock, Contributor),
"Survival outcome after Hodgkin's disease: A
report from the International data base on Hodgkin's
disease" Semin Oncol 1990;17:758-768.
Portlock CS. "Non-Hodgkin's lymphomas: Advances
in diagnosis, staging and management" Cancer
1990;65:718-722.
Portlock CS. "Management of the low-grade non-Hodgkin's
lymphomas" Semin Oncol 1990;17:51-59.
Portlock CS. "Advances in the treatment of lymphoma"
Current Opinion in Oncology 1990;2:838-842.
Golomb H, Ratain MJ, Fefer A, Golde DW, Ozer H, Portlock
CS, et al. "A randomized study of the duration
of treatment with interferon alpha-2b in hairy cell
leukemia patients" J Natl Cancer Inst 1988;80:369-373.
Schneider KC, Lichtenstein JL, Freeman JL, Newbold
RC, Fetter RB, Gottlieb L, Leaf PJ, and Portlock CS.
"Ambulatory visit groups: An outpatient classification
system" J Ambulatory Care Manage 1988;11:1-12.
Golomb HM, Fefer A, Golde DW, Ozer H, Portlock CS,
et al. "Report of a multi-institutional study
of 193 patients with hairy cell leukemia treated with
interferon-alfa 2b" Semin Oncol 1988;15(5):7-9.
Portlock CS. "GI tract lymphomas: The pathologists'
new diagnostic tools" J Clin Gastroenterol 1988;10:135-136.
Golomb HM, Fefer A, Golde DW, Ozer H, Portlock CS,
et al. "Sequential Evaluation of Alpha-2-Interferon
Treatment in 128 Patients with Hairy Cell Leukemia"
Semin Oncol 1987;14:13-17.
Leavitt RD Rantanatharathorn B, Ozer H, Ultman JE,
Portlock CS, et al. "Alpha-2b interferon in the
treatment of Hodgkin's disease and non-Hodgkin's lymphoma"
Semin Oncol XIV (Suppl 2) 1987:18-23.
Portlock CS, Fischer DS, Cadman E, et al. "High-dose
pulse chlorambucil in advanced, low grade non-Hodgkin's
lymphomas" Cancer Treat Rep 1987;71:1029-1031.
Portlock CS. "Alpha Interferon in the Treatment
of Non-Hodgkin's Lymphomas" Current Concepts
in Oncology 1987;9:2-6.
Koletsky AJ, Bertino JR, Farber LR, Prosnitz LR,
Kapp DS, Fischer D, and Portlock CS. "Second
Neoplasms in Patients with Hodgkin's Disease Following
Combined Modality Therapy" J Clin Oncol 1986;4:311-317.
Golomb HM, Jacobs A, Fefer A, Ozer H, Thompson J,
Portlock CS, Ratain M, Golde D, Vardimen J, Burke
JS, Brady J, Bonnem E, and Spiegel R. "Alpha-2-Interferon
Therapy of Hairy Cell Leukemia: A Multi-center study
of 64 patients" J Clin Oncol 1986;4:900-905.
Todd MB, Cadman EC, Newcomer LN, Holford TR, Farber
LR, Fischer DS, Waldron JA, Portlock CS, Camp B, Bertino
JR. "ACOMLA and COMLA for malignant lymphoma"
in Update on Treatment for Diffuse Large Cell Lymphoma,
ed. AT Skarin, Park Row Publishers, Inc. 1986;53-61.
Todd MB, Portlock CS, Farber LR, Holford TR, and
Bertino JR. "Prognostic Indicators in diffuse
large cell (histiocytic) lymphoma" Int J Radiat
Oncol Biol Phys 1986;12:593-601.
Krikorian JG, Portlock CS, and Mauch PM. "Hodgkin's
disease presenting below the diaphragm" J Clin
Oncol 1986;4:1551-1562.
Portlock CS. "Non-Hodgkin's Lymphoma" In
Hematologic Malignancies, ed. B. Hoogstraten. (Springer-Verlag,
Berlin), 1986:77-96.
Portlock CS. "Therapeutic Approaches to the
Treatment of Hairy Cell Leukemia" Semin Oncol
1986;13:55-59.
Leavitt RD, Kaplan S, Grimm M, Ozer H, Portlock CS,
Ratanatharathorn V, Kararnes C, Ultmann J, and Rudnick
S. "High and Low Dose Treatment for High and
Low Grade Non-Hodgkin's Lymphoma" Interferon
Alpha-2: Pre-Clinical and Clinical Evaluation (DL
Kisner and JF Smyth, ed.), Martinus Nijoff Publishers,
1985:57-73.
Carmen MD, Schornagel JH, Rivest RS, Srimatkandada
S, Portlock CS, Duffy TP, and Bertino JR. "Resistance
to Methotrexate Due to Gene Amplification in a Patient
with Acute Leukemia" J Clin Oncol 1984;2:16-20.
Luikart SH, Whitman GB, Portlock CS. "Adriamycin,
Vinblastine, and Mitomycin C Combination Chemotherapy
in Refractory Breast Carcinoma" Cancer 1984;54:1252-1255.
Portlock CS. "Hodgkin's Disease" Medical
Clin N Amer 1984;68:729-740.
Portlock CS. "Good Risk Non-Hodgkin's Lymphoma:
Aproaches to Management" Semin Hematol 1983;20:25-34.
Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney
DN, Gazdar AF, Portlock CS, and Minna JD. "Deletion
3p (14-23) Double Minute Chromosomes, and Homogeneously
Staining Regions in Human Small Cell Lung Cancer in
Gene Amplification" Robert T. Schimke, ed., Cold
Spring Harbor Laboratory, 1982.
Portlock CS. "The Deferral of Initial Therapy
in Advanced Indolent Lymphomas" Cancer Treat
Rep March 1982;66:417-419.
Torti FM, Portlock CS, Rosenberg SA, and Kaplan HS.
"Extralymphatic Hodgkin's Disease: Prognosis
and Response to Therapy" Amer J Med 1981;70:487-492.
Krikorian JG, Portlock CS, Cooney DP, and Rosenberg
SA. "Spontaneous Regression of Non-Hodgkin's
Lymphoma. A Report of Nine Cases" Cancer 1980;46:2093-2099.
Portlock CS. "Management of the Indolent Non-Hodgkin's
Lymphomas" Semin Oncol 1980;7:292-301.
Portlock CS and Rosenberg SA. "No Initial Therapy
for Stage III and IV Non-Hodgkin's Lymphomas of Favorable
Histologic Types" Ann Intern Med 1979;90:10-13.
Hoppe RT, Portlock CS, Glatstein E, Rosenberg SA,
and Kaplan HS. "Alternating Chemotherapy and
Irradiation in the Treatment of Advanced Hodgkin's
Disease" Cancer 1979;43:472-481.
Krikorian JG, Portlock CS, Rosenberg SA, and Kaplan
HS. "Hodgkin's Disease, Stages I and II Occurring
Below the Diaphragm" Cancer 1979;43:1866-1871.
Grant S and Portlock CS. "Current Concepts in
Small Cell Carcinoma of the Lung" Connecticut
Medicine 1979;43(12):779-782.
Portlock CS, Rosenberg SA, Glatstein E, and Kaplan
HS. "Impact of Salvage Treatment on Initial Relapses
in Patients with Hodgkin's Disease, Stages I-III"
Blood 1978;51:825-833.
Rosenberg SA, Kaplan HS, Glatstein EJ, and Portlock
CS. "Combined Modality Therapy of Hodgkin's Disease:
A Report on the Stanford Trials" Cancer 1978;42:991-1000.
Porzig KJ, Portlock CS, Robertson A, and Rosenberg
SA. "Treatment of Advanced Hodgkin's Disease
with B-CAVE: Therapy of Primary MOPP Failures and
Relapses" Cancer 1978;42:1705-1710.
Elias L, Portlock CS, and Rosenberg SA. "Combination
Chemotherapy of Diffuse Histiocytic Lymphoma with
Cyclophosphamide, Adriamycin, Vincristine, and Prednisone
(CHOP)" Cancer 1978;42:1705-1710.
Krikorian JG, Portlock CS, and Rosenberg SA. "Treatment
of Advanced Hodgkin's Disease with Adriamycin, Bleomycin,
Vinblastine, and Imidazole Carboxamide (ABVD) After
Failure of MOPP Therapy" Cancer 1978;41:2107-2111.
Portlock CS and Glatstein E. "The Non-Hodgkin's
Lymphomas: Current Concepts and Management" Ann
Rev Med 1978;29:81.
Portlock CS, Rosenberg SA. "Chemotherapy of
the Non-Hodgkin's Lymphoma: The Stanford Experience"
Cancer Treat Rep 1977;61:1049-1055.
Langston JW, Ricci DR, Portlock CS. "Nonhypoxemic
Hazards of Prolonged Myoclonus" Neurology 1977;27:542-545.
Portlock CS and Rosenberg SA. "Combination Chemotherapy
with Cyclophosphamide, Vincristine, and Prednisone
in Advanced Non-Hodgkin's Lymphomas" Cancer 1976;37:1275-1282.
Portlock CS, Rosenberg SA, Glatstein E, Kaplan HS.
"Treatment of Advanced Non-Hodgkin's Lymphomas
with Favorable Histologies: Preliminary Results of
a Prospective Trial" Blood 1976;47:747-757.
Jacobs C, Portlock CS, Rosenberg SA. "Prednisone
in MOPP Chemotherapy for Hodgkin's Disease" BMJ
1976;2:1469-1471.
|
